alovudine has been researched along with Paraganglioma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Millo, C; Pacak, K | 1 |
Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Merino, M; Millo, C; Pacak, K; Taieb, D | 1 |
2 other study(ies) available for alovudine and Paraganglioma
Article | Year |
---|---|
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Bone Neoplasms; Dideoxynucleosides; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radioactive Tracers | 2013 |
18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Cell Proliferation; Dideoxynucleosides; Dopamine; Female; Genetic Testing; Glycolysis; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reference Standards; Risk Factors; Whole Body Imaging | 2015 |